Prescient, a global biopharma services firm, has acquired Uptake (Uptake Strategies Ltd) for an undisclosed amount. This acquisition marks a significant expansion of Prescient's capabilities within the healthcare consultancy sector. The transaction sees Prescient fully integrate Uptake's operations and team, strengthening its strategic offerings to global pharmaceutical and biotech clients.
Uptake is an award-winning, industry-leading consultancy renowned for its practical, innovative support to global healthcare companies. Its core services span planning, strategy, capability development, launch, early commercialisation, and transformation. The company is dedicated to delivering rigorous, measurable improvements in commercial and medical performance, underpinned by principles of patient-centricity, trust, and integrity. In 2024, Uptake was recognised with The King's Award for Enterprise for International Trade, underscoring its global impact and expertise.
The acquisition is strategically driven by a desire to enhance Prescient's comprehensive suite of services and deepen its expertise in critical areas of pharmaceutical commercialisation. Uptake's established reputation for inspiring exceptional performance and its focus on positively changing patients’ lives align with Prescient's broader mission. This move is expected to create a more robust platform for delivering high-impact strategic consultancy across the biopharma industry.
Expected synergies from this integration include the ability to offer clients a broader and more integrated range of strategic solutions, from early commercialisation planning through to launch and transformation. By combining Prescient's existing strengths with Uptake's specialised consultancy, the combined entity aims to drive greater value and innovation for its global client base. The unified team will leverage shared knowledge and best practices to address complex challenges in the evolving healthcare landscape.
Looking forward, the combined Prescient and Uptake entity is poised to strengthen its position as a leading force in global healthcare consultancy. The integration is anticipated to foster continued growth, expand service reach, and ultimately enhance the ability to support clients in bringing life-changing therapies to patients worldwide.